| Brenton L. Saunders | Chairman of the Board and Chief Executive Officer | FY2025 | |
| Sam A. Eldessouky | Executive Vice President and Chief Financial Officer | FY2025 | |
| A. Robert D. Bailey | Executive Vice President and Chief Legal Officer | FY2025 | |
| Dr. Yehia Hashad | Executive Vice President of Research & Development and Chief Medical Officer | FY2025 | |
| Andrew J. Stewart | President, Global Pharmaceuticals and International Consumer | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.